PLoS ONE (Jan 2019)

Obstructive sleep apnea may increase the risk of Alzheimer's disease.

  • Sylwia Przybylska-Kuć,
  • Maciej Zakrzewski,
  • Andrzej Dybała,
  • Paweł Kiciński,
  • Grzegorz Dzida,
  • Wojciech Myśliński,
  • Andrzej Prystupa,
  • Barbara Mosiewicz-Madejska,
  • Jerzy Mosiewicz

DOI
https://doi.org/10.1371/journal.pone.0221255
Journal volume & issue
Vol. 14, no. 9
p. e0221255

Abstract

Read online

ObjectivesAmyloid-β 1-40 (Aβ 1-40) and amyloid-β 1-42 (Aβ 1-42) are the proteins known to be involved in the pathogenesis of Alzheimer's disease (AD)-the most common cause of dementia in the elderly. Hypoxia is suspected to be one of conditions associated with Aβ plasma level increase. A common reason of hypoxia is obstructive sleep apnea (OSA), characterized by recurrent episodes of apnea.AimThe aim of the study was to evaluate plasma Aβ 1-40 and Aβ 1-42 concentrations in patients with OSA.MethodsPatients with suspected OSA (n = 112) underwent polygraphic examinations Patients with confirmed OSA (n = 81) showed apnea/hypopnea index greater than or equal to 5. Mild and moderate form of the disease was defined when AHI was 5-30 (n = 38, OSA+), severe-when AHI was >30 (n = 43, OSA++). Individuals with AHIResultsAβ 1-40 concentrations in OSA++ (191.1 pg/ml) group was significantly (pConclusionIn patients with severe OSA Aβ 1-40 plasma concentrations are significantly higher compared with OSA- and OSA+ and seem to be related to hypoxia severity, which may indicate increased risk of AD development in this group of patients.